🇺🇸 FDA
Patent

US 8138312

Compositions for regulation of tumor necrosis factor-alpha

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 8138312 (Compositions for regulation of tumor necrosis factor-alpha) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P1/04